# LOUIS STOKES CLEVELAND VA MEDICAL CENTER: Immunogenicity of recombinant zoster vaccine in Rheumatoid arthritis patients

**Lab Budget Score:** 15/100

| Field | Value |
|---|---|
| Organization | LOUIS STOKES CLEVELAND VA MEDICAL CENTER |
| Location | CLEVELAND, OH |
| Project | Immunogenicity of recombinant zoster vaccine in Rheumatoid arthritis patients |
| Project number | 5I01CX002060-05 |
| Mechanism | I01 |
| Institute | Veterans Affairs |
| Awarded | 2026-09-18 |
| Project period | 2021-07-01 to 2026-06-30 |
| UEI | KHM6GRQMTKL1 |

## Why this score


Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11333512). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.